Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden Anstalt des öffentlichen Rechts des Freistaates Sachsen
Universitätsklinikum Carl Gustav Carus
ZKN Logo
  • The Center
    • Multiple Sclerosis Center Dresden
      • Patient Information
      • Contact MSC
      • Physicians & Nurses
      • Study Team
      • Neuropsychology
    • Mobility Center
      • The Mobility Center
      • Walking Assessment
      • Jump Assessment
      • DIERS
      • EMIQ
      • Projects
    • Neuroimmunological Laboratory
      • The NIL
      • Neurofilament light chain
    • Autonomic & Neuroendocrinological Functional Laboratory
      • The ANF
      • ANF Assessment
    • MS Living Lab
    • Management & Science
      • Team Management & Science
      • Projects
      • eHealth & Analytics
        • MSDS 3D
        • MSDS Clinic & Practice
        • MS-HRS
        • MTRS
      • Multiple Sclerosis Management
  • Aktuelles
    • Neuigkeiten
    • Publikationen
    • Veranstaltungen
      • Adventssymposium
      • MS Tag 2025
      • Multiple Sklerose 360°
      • Welt-MS-Tag 2021
    • Doktorarbeiten
    • Jobs
    • Kontakt
    • Spenden
  • Podcasts & Newsletter
    • Newsletter
    • Patienten-Podcast
    • Ärzte-Podcast
    • Neurovision
    • Digital calender 2026
    • Sherlock-MS-Blog
  • Studien
    • Interventionelle Studien
    • B-SHUTTLE
    • Nicht-interventionelle Studien
    • MS PATHS
    • Konectom
    • Sprachanalyse
MS 360 Grad
EnglishEnglish
DeutschDeutsch
EnglishEnglish

Treatment of multiple sclerosis with glatiramer acetate - New information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies

MS Treatments

Jahr

Publikationsjahr
2002

Autoren

Autorenliste der Publikation
Ziemssen T, Neuhaus O, Farina C, Hartung HP, Hohlfeld R.

Verlag

Publisher-Information
Nervenarzt 2002;73(4):321-331.

Link

Zur Publikation (externer Server)
https://link.springer.com/article/10.1007/s00115-001-1257-0

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2002

  • Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomes

    MASC
    Jahr
    2025

  • Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis

    NIL
    Jahr
    2025

  • Education Research: Can Large Language Models Match MS Specialist Training?

    MASC
    Jahr
    2025

  • A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis

    MS Treatments
    Jahr
    2025

  • Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis

    NIL
    Jahr
    2025
  • Start
  • Aktuelles
  • Publikationen
  • MS Treatments
  • Treatment of multiple sclerosis with glatiramer acetate - New information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies
Uniklinikum Carl Gustav Carus
UKD Neurologie
TU Dresden
Impressum & Datenschutz
MSZ @ Facebook
MSZ @ Google
ZKN @ Youtube

© 2025
Universitätsklinikum C.G. Carus Dresden an der Technischen Universität Dresden